Study on PADI2: Potential Drug Target and Biomarker for Various Diseases

Target Name: PADI2

NCBI ID: G11240

PADI2

Study on PADI2: Potential Drug Target and Biomarker for Various Diseases

PADI2 (padding-associated protein 2) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the PADI family of proteins, which are known for their role in the regulation of cell signaling pathways.

PADI2 has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its functions in these diseases have been studied extensively, and its potential as a drug target has led to the development of several new treatments.

One of the key functions of PADI2 is its role in the regulation of neurotransmitter release from nerve axons. This is important for the proper functioning of the nervous system, and is implicated in a wide range of neurological and psychiatric disorders.

In addition to its role in neurotransmitter release, PADI2 is also involved in the regulation of inflammation and cellular signaling pathways. It has been shown to play a key role in the regulation of T cell responses, which are important for immune surveillance against infection and disease.

The potential drug targets for PADI2 are numerous, and include targets that are involved in neurotransmitter release, inflammation, and cellular signaling pathways. Some of the most promising targets are those that are involved in the regulation of neurotransmitter release from axons, as this is a critical function for the nervous system.

One of the most promising targets for PADI2 is the neurotransmitter acetylcholine, which is involved in the regulation of memory and cognitive function. Studies have shown that PADI2 is involved in the regulation of acetylcholine release from nerve axons, and that defects in PADI2 have been linked to memory impairments and other cognitive disorders.

Another promising target for PADI2 is the protein PDGF-尾, which is involved in the regulation of cell signaling pathways. Studies have shown that PADI2 is involved in the regulation of PDGF-尾 signaling, and that defects in PADI2 have been linked to the development of certain diseases.

In addition to its potential as a drug target, PADI2 is also a potential biomarker for various diseases. Its expression has been shown to be altered in a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that PADI2 may be a useful diagnostic or predictive marker for these diseases.

Overall, PADI2 is a protein that has important functions in the regulation of neurotransmitter release and cellular signaling pathways. Its potential as a drug target or biomarker has led to the development of several new treatments for a wide range of neurological and psychiatric disorders. Further research is needed to fully understand its functions and potential as a drug target.

Protein Name: Peptidyl Arginine Deiminase 2

Functions: Catalyzes the deimination of arginine residues of proteins

The "PADI2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PADI2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets